article thumbnail

Article EMA Thank You New guidance provides definition for orphan device, offers alternative trial designs

Agency IQ

New guidance provides definition for orphan device, offers alternative trial designs New guidance from the European Commission outlines alternatives for full pre-market clinical trials for orphan devices, defined by the Commission for the first time. Does this guidance offer the formal definition of “orphan device” we’ve been waiting for?

Trials 40
article thumbnail

Article Periodic Thank You Commission unveils “one substance, one assessment” reform package

Agency IQ

Commission unveils “one substance, one assessment” reform package The Commission has long aspired to realize its one substance, one assessment concept in the EU’s chemical regulatory regime. Analysis One wonders what role the envisioned ECHA basic regulation will have in supporting this reform package.

article thumbnail

Product Highlight: DrugBank Data Dictionary

DrugBank

Your Definitive Source of Truth The Data Dictionary is tailored to transform your data experience, offering the official DrugBank perspective on every piece of information in our database. Enhanced User Experience By offering immediate access to detailed data definitions, the Data Dictionary saves you time and reduces errors.

article thumbnail

FDA Issues Long-Awaited QMSR Final Rule

FDA Law Blog: Biosimilars

Both ISO 13485 and ISO 9000 contain terms and definitions that are referenced within Part 820. FDA further retained some definitions in the QSMR. FDA further retained some definitions in the QSMR. Certain definitions are also removed from § 820.3, Revised § 820.3

FDA 57
article thumbnail

Tutorial 4 – Microservices – Discovery Client, LoadBalancer Client and Feign Client.

Perficient: Drug Development

Feign Client It is termed abstract client because we just supply an interface with method definition and annotation. So, other instances of the target may sit idle. To solve these problems, use the “ LoadBalancerClient ” type client component. return new ResponseEntity<String>("Final billAmount = billAmount - discount (RS.

Packaging 104
article thumbnail

Regulatory Developments in Ophthalmology: Applying New FDA Guidance, Part One

The Premier Consulting Blog

The new guidance provides detailed information to applicants and manufacturers regarding compliance with the requirements in 21 CFR Part 4 for ophthalmic drugs packaged with eye cups, eye droppers, or other dispensers.

FDA 52
article thumbnail

A Comprehensive Guide to Implementing BDD testing in Katalon Studio

Perficient: Drug Development

We will dive into creating a BDD Feature file and Step Definition file in Katalon Studio for a test case and perform execution of the test by two methods: Directly running the Feature file and utilizing in-built Keywords to run it from the Test Case. This article will explore how we can perform BDD testing in Katalon Studio.